Scarica l'app Stockscreener
2.74
13.22%
0.32
Dopo l'orario di chiusura:
2.74
Precedente Chiudi:
$2.42
Aprire:
$2.45
Volume 24 ore:
686.65K
Relative Volume:
1.87
Capitalizzazione di mercato:
$126.40M
Reddito:
$226.63M
Utile/perdita netta:
$15.38M
Rapporto P/E:
-54.80
EPS:
-0.05
Flusso di cassa netto:
$35.61M
1 W Prestazione:
-16.97%
1M Prestazione:
-4.86%
6M Prestazione:
-33.09%
1 anno Prestazione:
-28.83%
Intervallo 1D:
$2.32
$2.75
Intervallo di 1 settimana:
$2.32
$3.37
Portata 52W:
$2.225
$7.73
Puma Biotechnology Inc Stock (PBYI) Company Profile
Nome
Puma Biotechnology Inc
Settore
Industria
Telefono
(424) 248-6500
Indirizzo
10880 WILSHIRE BLVD., LOS ANGELES, CA
Confronta PBYI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| PBYI | 2.74 | 126.40M | 226.63M | 15.38M | 35.61M | -0.05 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-09-28 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Underperform |
| 2019-10-08 | Downgrade | Goldman | Neutral → Sell |
| 2019-05-10 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | Downgrade | Citigroup | Buy → Neutral |
| 2019-01-17 | Iniziato | Leerink Partners | Mkt Perform |
| 2019-01-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2018-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-11-02 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-17 | Iniziato | Goldman | Sell |
| 2018-05-11 | Reiterato | Stifel | Buy |
| 2017-11-10 | Reiterato | Citigroup | Buy |
| 2017-11-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | Reiterato | Stifel | Buy |
| 2017-09-11 | Reiterato | Credit Suisse | Outperform |
| 2017-07-10 | Ripresa | Leerink Partners | Outperform |
| 2017-06-06 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Puma Biotechnology Inc Borsa (PBYI) Ultime notizie
Los Angeles Capital Management LLC Acquires Shares of 245,695 Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat
Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St
We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance
Puma Biotechnology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Puma Biotechnology reports robust Q3 growth - Investing.com
Earnings call: Puma Biotechnology reports robust Q3 growth By Investing.com - Investing.com UK
Puma Biotechnology's (PBYI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up - Nasdaq
Puma Biotechnology Reports Strong Q3 2024 Growth - TipRanks
Puma Biotechnology Q3 2024 Earnings Preview - MSN
Puma Biotech (PBYI) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Puma Biotechnology Reports Third Quarter 2024 Financial Results - sharewise
Puma Biotech: Q3 Earnings Snapshot - San Francisco Chronicle
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - sharewise
Puma Biotechnology Grants 5,625-Share Inducement Award to New Employee | PBYI | PBYI Stock News - StockTitan
Puma Biotechnology (NASDAQ:PBYI) Raised to "Strong-Buy" at StockNews.com - MarketBeat
Puma Biotechnology (PBYI) Set to Announce Quarterly Earnings on Thursday - MarketBeat
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Puma Biotechnology, Inc. (NASDAQ - The Bakersfield Californian
Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - BioSpace
Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at StockNews.com - MarketBeat
What is Zacks Research's Forecast for PBYI FY2026 Earnings? - MarketBeat
Equities Analysts Offer Predictions for PBYI Q3 Earnings - MarketBeat
With A Return On Equity Of 18%, Has Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Management Done Well? - Yahoo Finance
Puma Biotechnology quickly drops after patents for Tagrisso ruled invalid - MSN
FY2025 EPS Estimates for Puma Biotechnology, Inc. (NASDAQ:PBYI) Decreased by Zacks Research - MarketBeat
Frazier Life Sciences Management L.P. Purchases 246,264 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat
Affinity Asset Advisors LLC Makes New $815,000 Investment in Puma Biotechnology, Inc. (NASDAQ:PBYI) - MarketBeat
Fred Alger Management LLC Raises Stake in Hamilton Lane Incorporated (NASDAQ:HLNE) - MarketBeat
Hsbc Holdings PLC Has $4.29 Million Position in Grupo Financiero Galicia S.A. (NASDAQ:GGAL) - MarketBeat
The growth track for Humacyte Inc (HUMA) has changed recently - SETE News
Humacyte: Navigating The FDA Uncertainty And ATEV’s Potential (NASDAQ:HUMA) - Seeking Alpha
Puma VCT 13 Launches £70M Share Offer - TipRanks
HUTCHMED (NASDAQ:HCM) Shares Gap Down to $17.38 - MarketBeat
It is Poised to be a Bull Market for Puma Biotechnology Inc (PBYI) - SETE News
American Century Companies Inc. Sells 186,924 Shares of Foot Locker, Inc. (NYSE:FL) - Defense World
Bank of America Raises Trupanion (NASDAQ:TRUP) Price Target to $56.00 - MarketBeat
Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter
Insider Selling: Sebelius Kathleen, Humacyte Inc [HUMA] Director divested 5,182 shares - Knox Daily
A$AP Rocky’s Lineup of Puma Sneakers Is Quickly Growing Bigger - Yahoo! Voices
Achilles gains on plans to explore strategic options - XM
Achilles Therapeutics Shares Are Trading Higher: What You Need To Know - Benzinga
Puma VCT 13 PLC Executes Share Buyback - TipRanks
A$AP Rocky’s Distressed PUMA Inhale Is Dropping In “Pop Red” - Sneaker News
A$AP Rocky's PUMA Inhale Distressed Appears in Black and Red - HYPEBEAST
A$ap Rocky x Puma Inhale Distressed Black / Pop RedSep 2024402453-01 - KicksOnFire.com
Puma Biotech's patent suit sees mixed verdict By Investing.com - Investing.com Australia
Upward Trajectory: Humacyte Inc (HUMA) Posts a Slidee, Closing at 5.28 - The Dwinnex
Puma Biotechnology rises on appeal of AstraZeneca Tagrisso patent dispute - MSN
Puma Biotechnology Inc Azioni (PBYI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):